Randomized Phase IB/II Study of Enzalutamide With and Without Ribociclib in Patients With Metastatic Castrate Resistant, Chemotherapy Naïve Prostate Cancer That Retains RB Expression
Phase of Trial: Phase I/II
Latest Information Update: 04 Dec 2017
At a glance
- Drugs Ribociclib (Primary) ; Enzalutamide
- Indications Prostate cancer
- Focus Adverse reactions; Therapeutic Use
- 28 Nov 2017 Planned primary completion date changed from 1 Sep 2020 to 14 Apr 2020.
- 17 Nov 2017 Planned number of patients changed from 117 to 90.
- 10 Jun 2017 Biomarkers information updated